Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce the font size Increase the font size  
 
 

About us

Contact Us

Sanofi

Sanofi House,
CTS No.117-B, L&T Business Park,
Saki Vihar Road, Powai,
Mumbai 400072

Tel no. (022) 28032000
Fax no.(022) 28032846

Content :

Growth platforms

Sanofi is focused on seeking growth relays through the diversification of its activities and its presence worldwide.

 

The world’s healthcare needs cannot be met by a single line of business. By 2012, we will lose 30% of our sales, with no equivalent compensation from our pipeline. New activities such as bio-techs, generics, vaccines will be our new sources of growth; all our business activities throughout the world, region by region, must focus on finding new growth opportunities.

Outside of prescription pharmaceuticals, we are creating or strengthening our other business activities such as vaccines, consumer healthcare (OTCs), branded generics and services. These will all be adapted worldwide: to each region, each country and each patient.

Our business development strategy is based on a structured policy of acquisitions and partnerships, which form or strengthen platforms for long-term growth, creating value for shareholders Sanofi is fully committed to unleashing all the creativity and innovation within the company. To do this, we intend to actively engage the world outside our walls.
The acquisitions of Zentiva, Medley, Kendricks, Acambis and Symbion Consumer, as well as Merial in animal health, are the first steps in this direction.

Updated March 19, 2010

Module :

Corporate information

Corporate information